相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Optimized Timing of Post-Transplantation Cyclophosphamide in MHC-Haploidentical Murine Hematopoietic Cell Transplantation
Lucas P. Wachsmuth et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)
Javier Bolanos-Meade et al.
LANCET HAEMATOLOGY (2019)
Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression
Lucas P. Wachsmuth et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Haploidentical hematopoietic cell and kidney transplantation for hematological malignancies and end-stage renal failure
Yi-Bin Chen et al.
BLOOD (2019)
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL
Peter Dreger et al.
BLOOD ADVANCES (2019)
Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide
Shannon R. McCurdy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study
Patrizia Chiusolo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Teaching a Young Dog New Tricks: Modifications to the Post-Transplantation Cyclophosphamide Haploidentical Transplantation Platform
Christopher G. Kanakry et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications
Antonio Russo et al.
BLOOD (2018)
Alloimmune T cells in transplantation
Susan DeWolf et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes
Yu Wang et al.
ONCOIMMUNOLOGY (2017)
Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide
Yvette L. Kasamon et al.
BLOOD ADVANCES (2017)
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide
Christopher G. Kanakry et al.
BLOOD (2017)
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors
Abraham S. Kanate et al.
BLOOD (2016)
Modern approaches to HLA-haploidentical blood or marrow transplantation
Christopher G. Kanakry et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation
M. Mielcarek et al.
BLOOD (2016)
Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis
Nilanjan Ghosh et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen
Jeffrey M. Dodd-o et al.
TRANSPLANTATION (2016)
Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide
Christopher G. Kanakry et al.
JCI INSIGHT (2016)
High Fever Occurring 4 to 5 Days Post-Transplant of Haploidentical Bone Marrow or Peripheral Blood Stem Cells after Reduced-Intensity Conditioning Associated with the Use of Post-Transplant Cyclophosphamide as Prophylaxis for Graft-versus-Host Disease
Paul O'Donnell et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells
Nicoletta Cieri et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
Shannon R. McCurdy et al.
BLOOD (2015)
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Stefan O. Ciurea et al.
BLOOD (2015)
Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation
Alessandra Roberto et al.
BLOOD (2015)
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation
Nicoletta Cieri et al.
BLOOD (2015)
HLA haploidentical peripheral blood stem cell transplantation using reduced dose of posttransplantation cyclophosphamide for poor-prognosis or refractory leukemia and myelodysplastic syndrome
Hirohisa Nakamae et al.
EXPERIMENTAL HEMATOLOGY (2015)
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
Yvette L. Kasamon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients
Heather Morris et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Alternative Donor Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
Christopher G. Kanakry et al.
SEMINARS IN HEMATOLOGY (2015)
Immune Reconstitution/Immunocompetence in Recipients of Kidney Plus Hematopoietic Stem/Facilitating Cell Transplants
Joseph R. Leventhal et al.
TRANSPLANTATION (2015)
Situational aldehyde dehydrogenase expression by regulatory T cells may explain the contextual duality of cyclophosphamide as both a pro-inflammatory and tolerogenic agent
Christopher G. Kanakry et al.
ONCOIMMUNOLOGY (2015)
Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice
Sudipto Ganguly et al.
BLOOD (2014)
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
Christopher G. Kanakry et al.
BLOOD (2014)
Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
Christopher G. Kanakry et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the US Registry
Loren Gragert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Post-transplant cyclophosphamide and bortezomib inhibit dendritic cell maturation and function and alter their IκB and NFκB
Ahmad Samer Al-Homsi et al.
TRANSPLANT IMMUNOLOGY (2014)
Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning
Anna Maria Raiola et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease
Everett H. Meyer et al.
BLOOD (2013)
Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
Christopher G. Kanakry et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Tolerance Induction in HLA Disparate Living Donor Kidney Transplantation by Donor Stem Cell Infusion: Durable Chimerism Predicts Outcome
Joseph Leventhal et al.
TRANSPLANTATION (2013)
Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial
Scott R. Solomon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell Transplantation
Joseph Leventhal et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
Leo Luznik et al.
SEMINARS IN ONCOLOGY (2012)
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
Mauro Di Ianni et al.
BLOOD (2011)
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
Leo Luznik et al.
BLOOD (2010)
High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation
Leo Luznik et al.
IMMUNOLOGIC RESEARCH (2010)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation
Vu H. Nguyen et al.
BLOOD (2007)
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide
PV O'Donnell et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation
L Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide
L Luznik et al.
BLOOD (2001)
Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia
RA Brodsky et al.
ANNALS OF INTERNAL MEDICINE (2001)
分享论文
